Biotech

All Articles

Lundbeck slashes value of $250M Abide acquistion after pain setback

.Lundbeck is actually lowering the book worth of its $250 million Abide Therapies buyout in reaction...

Real- World Data Satisfies Clinical Trial Design: Maximizing Protocols and also Internet Site Choice

.The integration of real-world data (RWD) right into protocol feasibility and internet site variety ...

Where are they right now? Overtaking previous Ferocious 15 honorees

.At this year's Intense Biotech Top in Boston ma, our team caught up with leaders in the biotech sec...

Merck purchases preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is taking down $30 million in advance to purchase Yale spinout Modifi Biosciences, a...

Radiopharma Alpha-9 elevates $175M collection C to cash medical push

.Alpha-9 Oncology has increased a $175 million collection C round to stake its clinical-stage radiop...

Ocuphire to transform in to gene treatment biotech by means of Opus purchase

.Eye medicine producer Ocuphire Pharma is actually getting genetics therapy programmer Opus Genetic ...

Roche culls hack prospect, turns KRAS course in Q3 upgrade

.Roche's persistent coughing plan has actually faltered to a stop. The drugmaker, which axed the sys...

Merck- Gilead long-acting dental combo reduces HIV for 48 weeks

.Gilead Sciences as well as Merck &amp Co. have helped their once-weekly HIV combo treatment past ye...

Lykos takes FDA watch that MDMA approval depends on new trial

.Lykos Therapies might have lost three-quarters of its workers back the FDA's rejection of its own M...

Septerna organizes $158M IPO to finance readouts for GPCR pipeline

.Septerna may be yet to divulge "any sort of purposeful clinical records," but the biotech clearly b...